Is amyloid beta peptide a driver of inflammaging?
- 29 July 2026
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 121, 103280
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education and Science of the Russian Federation
This publication has 353 references indexed in Scilit:
- MRI markers of cerebrospinal fluid dynamics predict dementia and mediate the impact of cardiovascular riskAlzheimer's & Dementia, 2025
- Cardioprotective Glucose-Lowering Agents and Dementia RiskJAMA Neurology, 2025
- Lecanemab preferentially binds to smaller aggregates present at early Alzheimer's diseaseAlzheimer's & Dementia, 2025
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Alzheimer's disease‐induced phagocytic microglia express a specific profile of coding and non‐coding RNAsAlzheimer's & Dementia, 2023
- Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progressionAlzheimer's & Dementia, 2023
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Blood‐brain barrier integrity impacts the use of plasma amyloid‐β as a proxy of brain amyloid‐β pathologyAlzheimer's & Dementia, 2023
- In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately failsAlzheimer's & Dementia, 2022
- Autoantibodies to amyloid-? and Alzheimer's diseaseAnnals of Neurology, 2001